<code id='7247387A70'></code><style id='7247387A70'></style>
    • <acronym id='7247387A70'></acronym>
      <center id='7247387A70'><center id='7247387A70'><tfoot id='7247387A70'></tfoot></center><abbr id='7247387A70'><dir id='7247387A70'><tfoot id='7247387A70'></tfoot><noframes id='7247387A70'>

    • <optgroup id='7247387A70'><strike id='7247387A70'><sup id='7247387A70'></sup></strike><code id='7247387A70'></code></optgroup>
        1. <b id='7247387A70'><label id='7247387A70'><select id='7247387A70'><dt id='7247387A70'><span id='7247387A70'></span></dt></select></label></b><u id='7247387A70'></u>
          <i id='7247387A70'><strike id='7247387A70'><tt id='7247387A70'><pre id='7247387A70'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:946
          Change Healthcare logo, displayed on a screen, as seen through a magnifying glass — coverage from STAT
          Adobe

          Some of the country’s biggest health insurers said Tuesday that up to one-quarter of their claims are run through Change Healthcare, UnitedHealth Group’s technology company that sustained a massive cyberattack two weeks ago.

          Speaking at investor conferences, executives from Humana, Elevance Health, and CVS Health, which owns Aetna, said the biggest impact they’re seeing is fewer bills coming in from providers. For insurers, that means less visibility into how much they’ll have to pay for their members’ medical care in the beginning of the year, although they noted that providers and pharmacies have adopted workarounds that are helping the situation.

          advertisement

          “This past weekend we saw a significant increase in activity levels relative to recent years, which suggests in large part that providers are catching up their submissions,” Mark Kaye, Elevance’s chief financial officer, said at TD Cowen’s annual health care conference. Elevance was previously Anthem.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          White House announces new plan to address the growing threat of xylazine in overdose crisis
          White House announces new plan to address the growing threat of xylazine in overdose crisis

          RahulGupta,theBidenAdministration'sdrugczar,saidthegovernmentisusing"everyleverwehavetoprotectpublic

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Study points to new risk in gene therapy death of Terry Horgan

          TerryHorganinhisfamily'sMontourFalls,N.Y.,home,inanundatedphoto.KateCollins/TheJournalviaAPLastOctob